June 2018—Bryan Bohman, MD, doesn’t spend his days wandering the Bay Area handing out buttons that read “Lift people, not the bottom line.” But don’t rule this out as a possibility someday, either. Dr. Bohman, chief medical officer, University Healthcare Alliance, and clinical professor of anesthesiology and perioperative and pain medicine, Stanford Health Care, is campaigning against physician burnout. Yes, it threatens the quality of medical care, he says, and yes, it’s expensive.
Read More »June 2018
For one laboratory, a workflow transformation
June 2018—“Form follows function” is a famous design principle, coined by an architect. But in the health care system and elsewhere, perfect matches between form and function are scarce.
Read More »NGS to take top spot as cancer biomarker testing broadens
June 2018—For biomarker testing and tissue conservation, all roads lead to next-generation sequencing, says Boaz Kurtis, MD, laboratory and medical director of Cancer Genetics in Los Angeles. Dr. Kurtis said, “There’s no other technology platform out there that can provide the amount of data we need today or will need in the future.”
Read More »Questions about frozen tissue, preanalytic variables, tumor content
June 2018—Boaz Kurtis, MD, laboratory and medical director of Cancer Genetics in Los Angeles, took the following questions from attendees at a webinar on NGS in routine non-small cell lung cancer biomarker testing.
Read More »Satisfaction high with new automated AMH assays
June 2018—Testing for anti-müllerian hormone got a boost in 2017 when the year began and ended with the FDA clearing the first two fully automated AMH assays from Roche and Beckman Coulter.
Read More »Core needle biopsy of the breast: cases and cautions
June 2018—With core needle biopsies of the breast, if something looks like an epithelial malignancy, ask yourself: Is it really a carcinoma? If it is a carcinoma, ask yourself if it is a primary breast carcinoma.
Read More »Instrument acquisition, skilled labor on the table: Makers of chemistry, immunoassay analyzers answer our questions
June 2018—Broad menus, efficient workflows, single platforms, rural labs, cybersecurity, and economics are some of what one CEO and three marketing and product managers talked to CAP TODAY about when we spoke to four companies whose analyzers are profiled in the product guide.
Read More »New reference guide for ultrasound-guided FNA
June 2018—CAP Press released last month a new reference guide, Ultrasound Features of Superficial and Palpable Lesions. It’s small and spiral bound and has a laminated cover and tabs for easy reference. There are 375 images and illustrations in the guide’s 200 pages.
Read More »Q&A column
June 2018—What is the role of total testosterone and free testosterone in gauging the effectiveness of androgen deprivation therapy?
We are planning to validate the mismatch repair panel in our immunohistochemistry laboratory. Do we use the CAP guidelines for antibody validation for a nonpredictive marker or a predictive marker?
Clinical Pathology Abstracts
June 2018—Multiple myeloma and precursor disease in firefighters at World Trade Center disaster; Association between time to colonoscopy after a positive fecal test and colorectal cancer
Read More »Anatomic Pathology Abstracts
June 2018—Impact of pattern of invasion in invasive endocervical adenocarcinoma; Inflammatory myofibroblastic tumor of the uterus: an analysis of 13 cases.
Read More »Molecular Pathology Abstracts
June 2018—Genetics and pathogenesis of diffuse large B-cell lymphoma: Understanding the genetic basis of diffuse large B-cell lymphoma is important for understanding the pathogenesis of the disease and the molecular attributes that may influence therapeutic response.
Read More »Newsbytes
June 2018—Electronic device shows promise for identifying pathology specimens: While barcodes and radio-frequency identification are considered the workhorses of pathology specimen identification, a new technology, nearly two decades in the making, may soon get a piece of the action.
Read More »Put It on the Board
June 2018—FDA clears T2Bacteria panel for detecting sepsis-causing pathogens: T2 Biosystems received market clearance from the Food and Drug Administration for the T2Bacteria panel for the direct detection of bacterial species in human whole blood specimens from patients with suspected bloodstream infections.
Read More »Letters
June 2018—LCIS variants and DCIS: We write in response to the article by Karen Lusky regarding tips to distinguish DCIS from variant forms of LCIS (April 2018). A different question might be: Is it actually important to distinguish these two in situ proliferations?
Read More »From the President’s Desk—CAP18: bringing it all back home
June 2018—Nobody has an annual meeting like ours. Nobody. And CAP18 will be no exception. The CAP18 educational program features 85 courses presented by 128 outstanding faculty. A quick scan of the program reveals 42 new learning opportunities and another 38 returning by popular demand.
Read More »